Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight.
S CaprioTania PilliSilvia CantaraF SestiniC FioravantiC CiuoliC DalmiglioA CorboMaria Grazia CastagnaPublished in: BMC endocrine disorders (2024)
Since DA and normalization of prolactin are known to improve insulin sensitivity, we speculated they have favored the increase of IGF-1 in OV/OB. Our results should be confirmed and the hypothesis proven by further studies.